 |
|
|
| |
Emergence of HIV-1 Drug Resistance Through Week 48 in the Global Women's WAVES Study:
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs. Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF
|
| |
| |
Reported by Jules Levin
ID Week 2016 Oct 26-30 New Orleans
R Kulkarni1, SL Hodder2, H Cao1, S Chang1, MD Miller1, KL White1
1Gilead Sciences, Inc., Foster City, CA, USA; 2West Virginia University, Morgantown, PA, USA
|
| |
|
|
|
|
|
